MeiraGTx Holdings (MGTX) Net Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) reported Net Margin of 20.02% for Q4 2025, up 20421.0% on a YoY basis from N/an in Q4 2024, and up 100.16% quarter-over-quarter from 12320.24% in Q3 2025.
MeiraGTx Holdings (MGTX) Net Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Net Margin for 7 years, with the latest figure at 20.02% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin rose 20421.0% year-over-year to 20.02%; the trailing twelve-month figure through Dec 2025 stood at 113.23% (up 33086.0% YoY), and the FY2025 full-year result was 140.31%, up 30379.0% from the prior year.
- Net Margin for Q4 2025 stood at 20.02%, up from 12320.24% in the prior quarter.
- The five-year high for Net Margin was 990.93% in Q4 2023, with the low at 17241.13% in Q2 2024.
- Historically, Net Margin has averaged 2007.64% across 5 years, with a median of 513.97% in 2021.
- Annual changes were most pronounced in 2024 — Net Margin plunged 1640551 bps — and 2025, when it surged 1619006 bps.
- MeiraGTx Holdings' Net Margin stood at 47.1% in 2021, then surged by 1197 bps to 516.51% in 2022, then surged by 92 bps to 990.93% in 2023, then sank by 119 bps to 184.19% in 2024, then surged by 111 bps to 20.02% in 2025.
- The last three Net Margin figures came in at 20.02% (Q4 2025), 12320.24% (Q3 2025), and 1051.07% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 20.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.02% |
| Sep 30, 2025 | -12,320.24% |
| Jun 30, 2025 | -1,051.07% |
| Dec 31, 2024 | -184.19% |
| Sep 30, 2024 | -360.49% |
| Jun 30, 2024 | -17,241.13% |
| Mar 31, 2024 | -2,932.86% |
| Dec 31, 2023 | 990.93% |
| Sep 30, 2023 | -868.06% |
| Jun 30, 2023 | -835.62% |
| Mar 31, 2023 | -910.74% |
| Dec 31, 2022 | 516.51% |
| Sep 30, 2022 | -774.17% |
| Jun 30, 2022 | -315.76% |
| Mar 31, 2022 | -551.13% |
| Dec 31, 2021 | -47.10% |
| Sep 30, 2021 | -373.42% |
| Jun 30, 2021 | -392.61% |
| Mar 31, 2021 | -513.97% |
| Dec 31, 2020 | -276.16% |